Voice and Swallow Outcomes After Office-based Injection Laryngoplasty in Patients With Glottal Insufficiency

Launched by SOHAG UNIVERSITY · Nov 29, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how a treatment called injection laryngoplasty affects voice quality and swallowing in patients who have a condition known as glottal insufficiency, which means there is a gap in the vocal cords that can lead to problems with speaking and swallowing. The treatment involves injecting a substance called hyaluronic acid into the vocal cords to help improve their function. Researchers will check how patients are doing at 1, 3, and 6 months after the procedure.

To participate in this trial, you need to be between 65 and 74 years old and have issues with your voice (called dysphonia), which may include difficulty swallowing. You should also have been experiencing these problems for at least 1-2 months. However, if you have certain health issues, like severe heart problems or active throat cancer, you won't be able to take part. If you do join the study, you can expect follow-up visits to monitor your progress and see how the treatment is helping your voice and swallowing abilities.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. The complaint of all patients is dysphonia with or without aspiration
• • 2. Patients with small or large glottic gap
• • 3. Patients at least 1-2 months after the onset of GI
• Exclusion Criteria:
• • Patients who are 1- \>18 years old 2-Irritable 3-Exaggerated gag reflexes 4-Cardiac problems 5-Active laryngeal carcinoma 6-Patients on chemo or radiotherapy
• • -